TrialThe Journal of antimicrobial chemotherapy2024

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine.

Elisa de Lazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.